FOSECOIND
Foseco India Limited
Specialty chemicals for metal-casting and foundry consumables
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
fosecoindia.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Foseco India (FIL) supplies foundry consumables and related solutions to metal-casting foundries in India, and describes itself as part of the Vesuvius Group.
Company snapshot
24thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Cash flow from operations is higher than reported profit — earnings quality looks solid.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 187 Cr | 202 Cr | 231 Cr |
| Operating expenses (approx.) | 145 Cr | 161 Cr | 178 Cr |
| EBITDA | 42 Cr | 41 Cr | 53 Cr |
| OPM % | 22.4% | 20.5% | 23.0% |
| Other income | 5 Cr | 8 Cr | 5 Cr |
| Interest | 0.05 Cr | 0.11 Cr | 0.08 Cr |
| Depreciation | 6 Cr | 8 Cr | 8 Cr |
| Profit before tax | 24 Cr | 44 Cr | 50 Cr |
| Tax % | 35.6% | 23.2% | 27.4% |
| Net profit | 15 Cr | 33 Cr | 36 Cr |
| EPS (₹) | ₹17.97 | ₹44.86 | ₹44.74 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Dec 2025 | TTM |
|---|---|---|
| Sales | 643 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 519 Cr | Sign in free for the trailing twelve months |
| EBITDA | 124 Cr | Sign in free for the trailing twelve months |
| OPM % | 19.3% | Sign in free for the trailing twelve months |
| Other income | 17 Cr | Sign in free for the trailing twelve months |
| Interest | 0.16 Cr | Sign in free for the trailing twelve months |
| Depreciation | 13 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 106 Cr | Sign in free for the trailing twelve months |
| Tax % | 29.1% | Sign in free for the trailing twelve months |
| Net profit | 75 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹110.46 | Sign in free for the trailing twelve months |
| Dividend payout % | 21.4% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 |
|---|---|
| Equity capital | 8 Cr |
| Reserves | 1,029 Cr |
| Borrowings | — |
| Other liabilities | 248 Cr |
| Total liabilities | 1,368 Cr |
| Fixed assets (net) | 224 Cr |
| CWIP | 4 Cr |
| Investments | 0 Cr |
| Loans & advances | 0.21 Cr |
| Inventories | 54 Cr |
| Trade receivables | 153 Cr |
| Cash & bank | 97 Cr |
| Other assets | 836 Cr |
| Total assets | 1,368 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Dec 2025 |
|---|---|
| Cash from operating activity | 98 Cr |
| Cash from investing | -89 Cr |
| Cash from financing | -3 Cr |
| Net cash flow | 6 Cr |
| Free cash flow (OCF − Capex) | 89 Cr |
Ratios
| Metric | Dec 2025 |
|---|---|
| ROCE % | 9.4% |
| ROE % | 6.5% |
| Debtor days | 87 |
| Inventory days | 61 |
| Days payable | 178 |
| Cash conversion cycle | -30 |
| OCF / EBITDA % | 78.8% |
| Debt / equity | 0.00 |
| Current ratio | 2.90 |
| Net debt / EBITDA | -0.78 |